Cellular components

Cellular components, in the context of photodynamic therapy (PDT), refer to the collective biological structures—including lipids, proteins, and nucleic acids—that serve as the substrate for oxidative damage. This process is initiated when a photosensitizing drug is activated by a specific wavelength of light, leading to the production of reactive oxygen species (ROS), such as singlet oxygen and hydroxyl radicals (StatPearls, NBK470563). These ROS are highly reactive and have a very short diffusion radius, causing localized destruction of critical organelles like the mitochondria, lysosomes, and endoplasmic reticulum, as well as the plasma membrane (PMC3135103). The resulting widespread oxidative stress triggers various cell death pathways, including apoptosis and necrosis, and can also lead to the collapse of local tumor vasculature (NIH/NCI). PDT is clinically utilized for its ability to provide dual selectivity: the photosensitizer tends to accumulate more in diseased tissue, and the therapeutic effect is only triggered where light is precisely applied (PubMed, 2174033). This approach is widely used in the treatment of various malignancies, dermatological conditions like actinic keratosis, and ophthalmological diseases such as age-related macular degeneration.

Other names

Cellular components via reactive oxygen species-mediated photodynamic damagePhotodynamic therapy targetsROS-mediated cellular damageSinglet oxygen targetsPhotodynamic damage substrates

Generation of reactive oxygen species (ROS), primarily singlet oxygen, through Type I or Type II photochemical reactions following light activation of a photosensitizer, leading to non-specific oxidative degradation of cellular membranes and organelles.